People who type “clinical depression” into a Google search on a mobile device are now offered the option to take PHQ-9, a clinically validated screening questionnaire that tests what level of depression a person may be experiencing.
NAMI CEO Mary Giliberti said test results may help people take their first step toward treatment, including engaging in more informed conversations with their physicians.
“Clinical depression is a treatable condition which can impact many aspects of a person’s life,” Ms. Giliberti wrote in a Google blog post. “Statistics show that those who have symptoms of depression experience an average of a six to eight year delay in getting treatment after the onset of symptoms. We believe that awareness of depression can help empower and educate you, enabling quicker access to treatment.”
More articles on health IT:
GAO comptroller general concerned about federal CIO departures
Government entities see insider threat as No. 1 cybersecurity concern
McCain calls Trump admin ‘weak’ over lack of cyber policy
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
